Does INSULIN GLARGINE Cause Lipoatrophy? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Lipoatrophy have been filed in association with INSULIN GLARGINE (Lantus Solostar). This represents 0.0% of all adverse event reports for INSULIN GLARGINE.
8
Reports of Lipoatrophy with INSULIN GLARGINE
0.0%
of all INSULIN GLARGINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Lipoatrophy From INSULIN GLARGINE?
Of the 8 reports.
Is Lipoatrophy Listed in the Official Label?
Yes, Lipoatrophy is listed as a known adverse reaction in the official FDA drug label for INSULIN GLARGINE.
What Other Side Effects Does INSULIN GLARGINE Cause?
Blood glucose increased (19,234)
Inappropriate schedule of product administration (8,982)
Product storage error (7,743)
Off label use (6,842)
Visual impairment (5,793)
Blood glucose decreased (4,552)
Drug ineffective (4,351)
Hypoglycaemia (4,212)
Injection site pain (3,574)
Device issue (3,175)
What Other Drugs Cause Lipoatrophy?
GLATIRAMER (218)
LAMIVUDINE (30)
FINASTERIDE (29)
ZIDOVUDINE (22)
RITONAVIR (18)
STAVUDINE (18)
TRIAMCINOLONE ACETONIDE (18)
MEDROXYPROGESTERONE\MEDROXYPROGESTERONE (16)
ATAZANAVIR (14)
TRIAMCINOLONE (14)
Which INSULIN GLARGINE Alternatives Have Lower Lipoatrophy Risk?
INSULIN GLARGINE vs INSULIN GLARGINE-YFGN
INSULIN GLARGINE vs INSULIN GLARGINE\LIXISENATIDE
INSULIN GLARGINE vs INSULIN GLULISINE
INSULIN GLARGINE vs INSULIN HUMAN
INSULIN GLARGINE vs INSULIN LISPRO